Clinical Trial Update: Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating Abiraterone with prednisone or Darolutamide for advanced prostate cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Darolutamide (darolutamide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University of California, Davis | Conditions: Advanced Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 | Phase 2 | Status: RECRUITING